I-Captopril CAS: 62571-86-2 uMboneleli woMvelisi

I-Captopril nayo ibonakaliswe ukuba inqanda ukwakheka kwe-angiotensin II, i-peptide ye-bioactive evuselela i-angiogenesis kunye nokwandisa ubuninzi be-microvessel.I-Captopril ibonisa ukuvinjelwa okungenakukhuphisana komsebenzi we-tyrosinase monophenolase kunye nokuthintela ukukhuphisana komsebenzi we-diphenolase.I-Captopril, kunye nezinye i-ACE inhibitors, ibonakaliswe kunyango lwe-hypertension, ukungaphumeleli kwentliziyo, ukungasebenzi kwe-ventricular ekhohlo emva kwe-myocardial infarction, kunye ne-diabetic nephropathy. unyango lwe-nephropathy yesifo seswekile eyayanyaniswa nohlobo loku-I lwesifo seswekile esixhomekeke kwi-insulin, i-captopril yehlisa izinga lokuqhubekeka kokusilela kwezintso kwaye ibambezele ukuwohloka kokusebenza kwezintso.